4.5 Article

Proteomic and metabolomic analysis of cardioprotection: Interplay between protein kinase C epsilon and delta in regulating glucose metabolism of murine hearts

期刊

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.yjmcc.2008.10.008

关键词

Proteomics; Metabolism; Cardioprotection; Protein kinase C; Mitochondria; Preconditioning

资金

  1. British Heart Foundation
  2. Oak Foundation
  3. NIH [HL-76526, HL63901, HL654311, HL 80691, HL-80111]
  4. British Heart Foundation [FS/08/002/24537] Funding Source: researchfish

向作者/读者索取更多资源

We applied a combined proteomic and metabolomic approach to obtain novel mechanistic insights in PKC epsilon-mediated cardioprotection. Mitochondrial and cytosolic proteins from control and transgenic hearts with constitutively active or dominant negative PKC epsilon were analyzed using difference in-gel electrophoresis (DICE). Among the differentially expressed proteins were creatine kinase, pyruvate kinase, lactate clehydrogenase, and the cytosolic isoforms of aspartate amino transferase and malate dehydrogenase, the two enzymatic components of the malate aspartate shuttle, which are required for the import of reducing equivalents from glycolysis across the inner mitochondrial membrane. These enzymatic changes appeared to be dependent on PKC epsilon activity, as they were not observed in mice expressing inactive PKC epsilon. High-resolution proton nuclear magnetic resonance (H-1-NMR) spectroscopy confirmed a pronounced effect of PKC epsilon activity on cardiac glucose and energy metabolism: normoxic hearts with constitutively active PKC epsilon had significantly lower concentrations of glucose, lactate, glutamine and creatine, but higher levels of choline, glutamate and total adenosine nucleotides. Moreover, the depletion of cardiac energy metabolites was slower during ischemia/reperfusion injury and glucose metabolism recovered faster upon reperfusion in transgenic hearts with active PKC epsilon. Notably, inhibition of PKC epsilon resulted in compensatory phosphorylation and mitochondrial translocation of PKC delta. Taken together, our findings are the first evidence that PKC epsilon activity modulates cardiac glucose metabolism and provide a possible explanation for the synergistic effect of PKC delta and PKC epsilon in cardioprotection. (C) 2008 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Cardiac & Cardiovascular Systems

Methods for the identification and characterization of extracellular vesicles in cardiovascular studies: from exosomes to microvesicles

Sean M. Davidson, Chantal M. Boulanger, Elena Aikawa, Lina Badimon, Lucio Barile, Christoph J. Binder, Alain Brisson, Edit Buzas, Costanza Emanueli, Felix Jansen, Miroslava Katsur, Romaric Lacroix, Sai Kiang Lim, Nigel Mackman, Manuel Mayr, Philippe Menasche, Rienk Nieuwland, Susmita Sahoo, Kaloyan Takov, Thomas Thum, Pieter Vader, Marca H. M. Wauben, Kenneth Witwer, Joost P. G. Sluijter

Summary: This article provides an overview of the techniques and technologies available for the separation and characterization of EVs from different sources. It discusses methods for determining the protein, RNA, and lipid content of EVs. The guidance provided in this document is important for investigating the role of EVs in cardiovascular diseases and highlights key methodological issues to consider.

CARDIOVASCULAR RESEARCH (2023)

Editorial Material Endocrinology & Metabolism

Sexual dimorphism in COVID-19: potential clinical and public health implications

Nicole Bechmann, Andreas Barthel, Andreas Schedl, Stephan Herzig, Zsuzsanna Varga, Catherine Gebhard, Manuel Mayr, Constanze Hantel, Felix Beuschlein, Christian Wolfrum, Nikolaos Perakakis, Lucilla Poston, Cynthia L. Andoniadou, Richard Siow, Raul R. Gainetdinov, Arad Dotan, Yehuda Shoenfeld, Geltrude Mingrone, Stefan R. Bornstein

Summary: Current evidence shows that COVID-19 severity and mortality are higher in men compared to women, while women may be at a higher risk of reinfection and long-term COVID-19 development. Differences between sexes have also been observed in other infectious diseases and vaccine responses. This could be explained by sex-specific expression patterns of proteins involved in virus binding and entry, as well as divergent reactions of the immune and endocrine systems to acute stress. Understanding the role of sex hormones, comorbidities, and sex chromosome complement in COVID-19 could have implications for disease treatment, public health measures, and follow-up of patients predisposed to long COVID. Considering sex differences in future pandemic surveillance and COVID-19 patient treatment may lead to better disease stratification and improved outcomes.

LANCET DIABETES & ENDOCRINOLOGY (2022)

Review Oncology

Succinate dehydrogenase and MYC-associated factor X mutations in pituitary neuroendocrine tumours

Paul Benjamin Loughrey, Federico Roncaroli, Estelle Healy, Philip Weir, Madhu Basetti, Ruth T. Casey, Steven J. Hunter, Marta Korbonits

Summary: Pituitary neuroendocrine tumours (PitNETs) associated with paragangliomas or phaeochromocytomas are rare, but are linked to SDHx and MAX variants. Prolactinomas are the most common type of PitNETs, followed by somatotrophinomas, clinically non-functioning tumours, and corticotrophinomas in SDHx variant patients.

ENDOCRINE-RELATED CANCER (2022)

Editorial Material Cardiac & Cardiovascular Systems

SGLT2 Inhibitors in Heart Failure: Targeted Metabolomics and Energetic Metabolism

Carlos G. Santos-Gallego, Manuel Mayr, Juan Badimon

CIRCULATION (2022)

Article Hematology

Temporal in vivo platelet labeling in mice reveals age-dependent receptor expression and conservation of specific mRNAs

Paul C. Armstrong, Harriet E. Allan, Nicholas S. Kirkby, Clemens Gutmann, Abhishek Joshi, Marilena Crescente, Jane A. Mitchell, Manuel Mayr, Timothy D. Warner

Summary: This study developed a method to label platelet age and found that young platelets exhibit different functional and molecular characteristics compared to older platelets, with increased responsiveness and contribution to thrombus formation. The decrease in thrombotic function with age is accompanied by changes in surface protein expression.

BLOOD ADVANCES (2022)

Article Cell Biology

Vascular smooth muscle cell senescence accelerates medin aggregation via small extracellular vesicle secretion and extracellular matrix reorganization

Meredith Whitehead, Syabira Yusoff, Sadia Ahmad, Lukas Schmidt, Manuel Mayr, Jillian Madine, David Middleton, Catherine M. Shanahan

Summary: Vascular amyloidosis, caused by the aggregation of peptide monomers into insoluble amyloid, is a common age-related pathology. This study found that extracellular vesicles (EVs) and HSPG2 in the extracellular matrix (ECM) play key roles in medin accumulation, contributing to the development of age-associated aortic medial amyloid (AMA).

AGING CELL (2023)

Editorial Material Cardiac & Cardiovascular Systems

SGLT2 inhibitors in heart failure: insights from plasma proteomics

Clemens Gutmann, Thomas A. Zelniker, Manuel Mayr

EUROPEAN HEART JOURNAL (2022)

Review Biochemical Research Methods

Western blotting (immunoblotting): history, theory, uses, protocol and problems

Rasheed Sule, Gabriela Rivera, Aldrin Gomes

Summary: Western blotting is a powerful technique for detecting or semiquantifying individual proteins from complex mixtures of cell or tissue extracts. This article provides a comprehensive overview of the history, theory, protocol, and applications of western blotting. It also discusses lesser known but significant problems in the field and troubleshooting techniques. This work serves as a primer and guide for new western blotting researchers and those seeking a better understanding of the technique or improved results.

BIOTECHNIQUES (2023)

Editorial Material Cardiac & Cardiovascular Systems

Reducing reductionism: addressing risk for atherosclerotic cardiovascular disease by apolipoprotein proteomics

Lukas E. Schmidt, Walter S. Speidl, Sotirios Tsimikas, Manuel Mayr

EUROPEAN HEART JOURNAL (2023)

Review Cardiac & Cardiovascular Systems

Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction

Nick S. Nurmohamed, Jordan M. Kraaijenhof, Manuel Mayr, Stephen J. Nicholls, Wolfgang Koenig, Alberico L. Catapano, Erik S. G. Stroes

Summary: Given the limited accuracy of clinically used risk scores, novel risk algorithms based on proteomics and lipidomics data could provide more reliable ASCVD risk prediction. Retrospective studies have consistently shown the additive prognostic value of these panels over traditional risk scores, and prospective studies are needed to determine their clinical utility.

EUROPEAN HEART JOURNAL (2023)

Article Cell Biology

Desmosomal protein degradation as an underlying cause of arrhythmogenic cardiomyopathy

Hoyee Tsui, Sebastiaan Johannes van Kampen, Su Ji Han, Viviana Meraviglia, Willem B. van Ham, Simona Casini, Petra van der Kraak, Aryan Vink, Xiaoke Yin, Manuel Mayr, Alexandre Bossu, Gerard A. Marchal, Jantine Monshouwer-Kloots, Joep Eding, Danielle Versteeg, Hesther de Ruiter, Karel Bezstarosti, Judith Groeneweg, Sjoerd J. Klaasen, Linda W. Van Laake, Jeroen A. A. Demmers, Geert J. P. L. Kops, Christine L. Mummery, Toon A. B. Van Veen, Carol Ann Remme, Milena Bellin, Eva van Rooij

Summary: Arrhythmogenic cardiomyopathy (ACM) is a progressive cardiac disease caused by inherited mutations, such as plakophilin-2 (PKP2), which lead to decreased expression of desmosomal and adherens junction (AJ) proteins. In vitro and in vivo experiments demonstrated impaired contractility, cardiac dysfunction, and fibrosis associated with PKP2 mutations. Proteomics analysis revealed the involvement of the ubiquitin-proteasome system (UPS) in ACM pathogenesis, and inhibition of UPS improved cardiomyocyte function. The study highlights the potential therapeutic strategy of targeting protein degradation and improving desmosomal protein stability for ACM treatment.

SCIENCE TRANSLATIONAL MEDICINE (2023)

Article Cardiac & Cardiovascular Systems

Proteomic Atlas of Atherosclerosis: The Contribution of Proteoglycans to Sex Differences, Plaque Phenotypes, and Outcomes

Konstantinos Theofilatos, Stefan Stojkovic, Maria Hasman, Sander W. van der Laan, Ferheen Baig, Javier Barallobre-Barreiro, Lukas Emanuel Schmidt, Siqi Yin, Xiaoke Yin, Sean Burnap, Bhawana Singh, Jude Popham, Olesya Harkot, Stephanie Kampf, Maja Carina Nackenhorst, Andreas Strassl, Christian Loewe, Svitlana Demyanets, Christoph Neumayer, Martin Bilban, Christian Hengstenberg, Kurt Huber, Gerard Pasterkamp, Johann Wojta, Manuel Mayr

Summary: Using proteomics, this study identified molecular types of atherosclerotic lesions and their associations with histology, imaging, and cardiovascular outcomes. Proteomic signatures of plaque inflammation and calcification were identified and validated. Sex differences in atherosclerosis were also revealed. Protein signatures were used to predict future cardiovascular mortality, outperforming imaging and histology.

CIRCULATION RESEARCH (2023)

Article Hematology

Effect of Alirocumab Added to High-Intensity Statin on Platelet Reactivity and Noncoding RNAs in Patients with AMI: A Substudy of the PACMAN-AMI Trial

Yasushi Ueki, Jonas D. Haner, Sylvain Losdat, Giuseppe Gargiulo, Hiroki Shibutani, Sarah Bar, Tatsuhiko Otsuka, Raminta Kavaliauskaite, Vera R. Mitter, Fabrice Temperli, David Spirk, Stefan Stortecky, George C. M. Siontis, Marco Valgimigli, Stephan Windecker, Clemens Gutmann, Konstantinos C. Koskinas, Manuel Mayr, Lorenz Raber

Summary: Alirocumab has no significant effect on platelet reactivity and platelet-derived noncoding RNAs in AMI patients receiving dual antiplatelet therapy with a potent P2Y12 inhibitor.

THROMBOSIS AND HAEMOSTASIS (2023)

Article Multidisciplinary Sciences

Human blood vessel organoids reveal a critical role for CTGF in maintaining microvascular integrity

Sara G. Romeo, Ilaria Secco, Edoardo Schneider, Christina M. Reumiller, Celio X. C. Santos, Anna Zoccarato, Vishal Musale, Aman Pooni, Xiaoke Yin, Konstantinos Theofilatos, Silvia Cellone Trevelin, Lingfang Zeng, Giovanni E. Mann, Varun Pathak, Kevin Harkin, Alan W. Stitt, Reinhold J. Medina, Andriana Margariti, Manuel Mayr, Ajay M. Shah, Mauro Giacca, Anna Zampetaki

Summary: The microvasculature is critical for the delivery of oxygen and metabolites throughout tissues. In this study, human blood vessel organoids (BVOs) were used to show that CTGF is a critical paracrine regulator of microvascular integrity that can restore pericyte coverage and vessel structure.

NATURE COMMUNICATIONS (2023)

Article Multidisciplinary Sciences

Phenylalanine-tRNA aminoacylation is compromised by ALS/FTD-associated C9orf72 C4G2 repeat RNA

Mirjana Malnar Crnigoj, Ursa Cercek, Xiaoke Yin, Manh Tin Ho, Barbka Repic Lampret, Manuela Neumann, Andreas Hermann, Guy Rouleau, Beat Suter, Manuel Mayr, Boris Rogelj

Summary: In this study, the authors found that the expansion of GGGGCC repeat in the C9orf72 gene leads to amyotrophic lateral sclerosis and frontotemporal dementia. They identified CCCCGG antisense repeat RNA as the main binder and inhibitor of phenylalanine-tRNA synthetase, resulting in decreased levels of tRNAphe and phenylalanine-rich proteins.

NATURE COMMUNICATIONS (2023)

Article Cardiac & Cardiovascular Systems

Epicardial deletion of Sox9 leads to myxomatous valve degeneration and identifies Cd109 as a novel gene associated with valve development

Andrew B. Harvey, Renelyn A. Woltes, Raymond N. Deepe, Hannah G. Tarolli, Jenna R. Drummond, Allison Trouten, Auva Zandi, Jeremy L. Barth, Rupak Mukherjee, Martin J. Romeo, Silvia G. Vaena, Ge Tao, Robin Muise-Helmericks, Paula S. Ramos, Russell A. Norris, Andy Wessels

Summary: This study highlights the importance of SOX9 in the regulation of epicardial cell invasion and emphasizes the role of EPDCs in regulating atrioventricular valve development and homeostasis. It also reports a novel expression profile of Cd109, a gene with previously unknown relevance in heart development.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2024)

Review Cardiac & Cardiovascular Systems

Mechanistic target of rapamycin in regulating macrophage function in inflammatory cardiovascular diseases

MariaSanta C. Mangione, Jinhua Wen, Dian J. Cao

Summary: mTOR, a mechanistic target of rapamycin, is an evolutionarily conserved pathway that plays a fundamental role in nutrient sensing, growth, metabolism, lifespan, and aging. Recent studies have highlighted the regulatory role of mTOR in innate immune responses and its involvement in the pathogenesis of cardiovascular diseases, especially in acute inflammation and atherosclerotic cardiovascular disease. This review also discusses mTOR's role in trained immunity, immune senescence, and clonal hematopoiesis, as well as its architecture and regulatory complexes.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2024)

Article Cardiac & Cardiovascular Systems

Classification of regulatory T cells and their role in myocardial ischemia-reperfusion injury

Junlin Li, Yajun Gong, Yiren Wang, Huihui Huang, Huan Du, Lianying Cheng, Cui Ma, Yongxiang Cai, Hukui Han, Jianhong Tao, Gang Li, Panke Cheng

Summary: Myocardial ischemia-reperfusion injury is closely related to the final infarct size in acute myocardial infarction. Regulatory T cells play an important role in the inflammatory response after AMI, but different subtypes of Tregs have different effects on the injury.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2024)

Article Cardiac & Cardiovascular Systems

β-hydroxybutyrate administered at reperfusion reduces infarct size and preserves cardiac function by improving mitochondrial function through autophagy in male mice

Yuxin Chu, Yutao Hua, Lihao He, Jin He, Yunxi Chen, Jing Yang, Ismail Mahmoud, Fanfang Zeng, Xiaochang Zeng, Gloria A. Benavides, Victor M. Darley-Usmar, Martin E. Young, Scott W. Ballinger, Sumanth D. Prabhu, Cheng Zhang, Min Xie

Summary: This study demonstrates that administering beta-hydroxybutyrate (beta-OHB) at the time of reperfusion can reduce infarct size and preserve cardiac function by activating autophagy and preserving mitochondrial homeostasis, potentially through mTOR inhibition.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2024)